BBOX1 promotes triple-negative breast cancer progression by controlling IP3R3 stability

被引：4
|
作者：
Liao, Chengheng [1 ]
Zhang, Qing [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2020年 / 7卷 / 06期
关键词：
TNBC; 2-OG dependent enzyme; therapeutic target;
D O I：
10.1080/23723556.2020.1813526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Limited therapeutic options impede the clinical outcome of triple-negative breast cancer (TNBC). Our recent study uncovered a novel signaling pathway implicating gamma-butyrobetaine hydroxylase 1 (BBOX1) in the control of cell growth in TNBC, via inositol 1, 4, 5-trisphosphate receptor type 3 (IP3R3) mediated calcium signaling which is essential for cellular energy metabolism.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple-negative breast cancer
    Li, Jie
    Liu, Liya
    Chen, Youqin
    Wu, Meizhu
    Lin, Xiaoying
    Shen, Zhiqing
    Cheng, Ying
    Chen, Xiaoping
    Weygant, Nathaniel
    Wu, Xiangyan
    Wei, Lihui
    Sferra, Thomas J.
    Han, Yuying
    Chen, Xi
    Shen, Aling
    Peng, Jun
    ONCOLOGY REPORTS, 2022, 47 (06)
  • [32] CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
    Yuxiang Lin
    Jie Zhang
    Yan Li
    Wenhui Guo
    Lili Chen
    Minyan Chen
    Xiaobin Chen
    Wenzhe Zhang
    Xuan Jin
    Meichen Jiang
    Han Xiao
    Chuan Wang
    Chuangui Song
    Fangmeng Fu
    Journal of Translational Medicine, 20
  • [33] USP1-mediated deubiquitination of KDM1A promotes the malignant progression of triple-negative breast cancer
    Su, Yang
    Du, Yan
    He, Wenguang
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2024, 38 (10)
  • [34] FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer
    Chen, Chen
    Ye, Leiguang
    Yi, Jinfeng
    Liu, Tong
    Li, Zhigao
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (03) : 515 - 533
  • [35] FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer
    Chen Chen
    Leiguang Ye
    Jinfeng Yi
    Tang Liu
    Zhigao Li
    Breast Cancer Research and Treatment, 2023, 201 : 515 - 533
  • [36] CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
    Li, Xiao
    Li, Jinpeng
    Xu, Liming
    Wei, Wei
    Cheng, Anyi
    Zhang, Lingxian
    Zhang, Mengna
    Wu, Gaosong
    Cai, Cheguo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [37] CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
    Xiao Li
    Jinpeng Li
    Liming Xu
    Wei Wei
    Anyi Cheng
    Lingxian Zhang
    Mengna Zhang
    Gaosong Wu
    Cheguo Cai
    Journal of Experimental & Clinical Cancer Research, 41
  • [38] LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
    Malvi, Parmanand
    Janostiak, Radoslav
    Chava, Suresh
    Manrai, Padmini
    Yoon, Esther
    Singh, Kamaljeet
    Harigopal, Malini
    Gupta, Romi
    Wajapeyee, Narendra
    ONCOGENESIS, 2020, 9 (08)
  • [39] Kynurenine-3-monooxygenase (KMO) protein promotes triple negative breast cancer progression
    Liu, C-Y.
    Huang, T-T.
    Lee, C-H.
    Wang, W-L.
    Lee, H-C.
    Tseng, L-M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer
    Acharya, Sunil
    Yao, Jun
    Li, Ping
    Zhang, Chenyu
    Lowery, Frank J.
    Zhang, Qingling
    Guo, Hua
    Qu, Jingkun
    Yang, Fei
    Wistuba, Ignacio I.
    Piwnica-Worms, Helen
    Sahin, Aysegul A.
    Yu, Dihua
    CANCER RESEARCH, 2019, 79 (16) : 4211 - 4226
12345